Why choose us?
NewYork-Presbyterian's sickle cell disease program was established in 1983 as one of only ten National Institutes of Health-funded Comprehensive Sickle Cell Centers in the country and is one of the most experienced in the world. Our children's hospitals are also New York State-designated newborn referral centers for infants found to have the disease during routine newborn screening tests. In addition, NewYork-Presbyterian's Dalio Center for Health Justice — which focuses on improving the quality of and access to health care for people from all backgrounds — has identified sickle cell disease as one of their priority programs.
For children receiving a stem cell transplant from a sibling, our institution developed a low-intensity conditioning regimen to decrease long-term side effects. We continue to participate in research to improve stem cell transplantation from an unrelated donor and assess ways to enhance the quality of life and preserve fertility in patients. As members of the National Sickle Cell Disease Clinical Trials Network, Columbia University, and Weill Cornell Medicine investigators participate in clinical trials aimed at improving the futures of children with sickle cell disease, such as a pivotal multicenter study now underway to assess the benefits of gene therapy. When you come to us for care, we'll customize the best plan of treatment to meet the needs of your child and family. Call us for an appointment and see what we can do for you.